These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7036971)

  • 21. Management of supraventricular tachycardias.
    Grogan EW; Waxman HL
    Cardiovasc Clin; 1985; 16(1):261-78. PubMed ID: 2874882
    [No Abstract]   [Full Text] [Related]  

  • 22. Encainide for atrial fibrillation associated with Wolff-Parkinson-White syndrome.
    Rinkenberger RL; Naccarelli GV; Miles WM; Markel ML; Dougherty AH; Prystowsky EN; Heger JJ; Zipes DP
    Am J Cardiol; 1988 Dec; 62(19):26L-30L. PubMed ID: 3144164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of patients with recurrence of ventricular tachyarrhythmias for electrical studies.
    Horowitz LN; Spielman SR; Greenspan AM; Webb CR
    Pacing Clin Electrophysiol; 1984 May; 7(3 Pt 2):499-504. PubMed ID: 6204307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Problems in the treatment of re-entrant arrhythmias: general considerations.
    Brugada P; Wellens HJ
    Eur Heart J; 1984 Sep; 5 Suppl B():51-7. PubMed ID: 6499871
    [No Abstract]   [Full Text] [Related]  

  • 25. Wolff-Parkinson-White syndrome presenting in atrial fibrillation.
    Schatz I; Ordog GJ; Karody R; Bhasin V
    Ann Emerg Med; 1987 May; 16(5):574-8. PubMed ID: 3565873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of atrioventricular conduction by programmed stimulation of the heart (WPW syndrome, bifascicular block)].
    Probst P
    Acta Med Austriaca Suppl; 1977; 6():1-41. PubMed ID: 266821
    [No Abstract]   [Full Text] [Related]  

  • 27. Beta-blocker therapy for the Wolff-Parkinson-White syndrome.
    Prystowsky EN; Greer S; Packer DL; Thompson KA; German LD
    Am J Cardiol; 1987 Aug; 60(6):46D-50D. PubMed ID: 2888300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ
    Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors regulating ventricular rates during atrial flutter and fibrillation in pre-excitation (Wolff-Parkinson-White) syndrome.
    Castellanos A; Myerburg RJ; Craparo K; Befeler B; Agha AS
    Br Heart J; 1973 Aug; 35(8):811-6. PubMed ID: 4729838
    [No Abstract]   [Full Text] [Related]  

  • 30. Irregular pacemaker tachycardia in a patient with WPW syndrome and an A-V universal pacemaker.
    Wehr M; Schmitt CG; Peter JH
    Pacing Clin Electrophysiol; 1984 May; 7(3 Pt 1):320-4. PubMed ID: 6204281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supraventricular tachycardias.
    Wu D
    JAMA; 1983 Jun; 249(24):3357-60. PubMed ID: 6854872
    [No Abstract]   [Full Text] [Related]  

  • 32. Refractory supraventricular tachycardias.
    Ticzon AR; Whalen RW
    Circulation; 1973 Mar; 47(3):642-53. PubMed ID: 4571059
    [No Abstract]   [Full Text] [Related]  

  • 33. Dissimilar atrial rhythms in a patient with the Wolff-Parkinson-White syndrome.
    Genetos BC; Gaum WE; Etharrar V; Zipes DP
    Chest; 1977 Nov; 72(5):663-6. PubMed ID: 913153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of an accessory atrioventricular pathway in reciprocal tachycardia. Observations in patients with and without the Wolff-Parkinson-White syndrome.
    Wellens HJ; Durrer D
    Circulation; 1975 Jul; 52(1):58-72. PubMed ID: 1132122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of surgical management of the Wolff-Parkinson-White syndrome.
    Sealy WC
    Am J Surg; 1983 Jun; 145(6):756-62. PubMed ID: 6859413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of the accessory conduction pathway on the ventricular rhythm rate in paroxysmal auricular fibrillation].
    Dabrowski A; Kołodziej P; Borkowski P
    Pol Arch Med Wewn; 1982; 68(3):109-15. PubMed ID: 7170226
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanisms determining the ventricular rate in wolff-parkinson-white arrhythmias.
    Castellanos A; Levy S; Befeler B; Myerburg RJ
    Adv Cardiol; 1975; 14():221-32. PubMed ID: 1136885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
    Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
    Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tachyarrhythmias related to Wolff-Parkinson-White syndrome.
    Chung EK
    Heart Lung; 1977; 6(2):262-8. PubMed ID: 584716
    [No Abstract]   [Full Text] [Related]  

  • 40. Wolff-Parkinson-White syndrome.
    Ruffy R; Sears M; Avioli LV
    Arch Intern Med; 1985 Mar; 145(3):533-6. PubMed ID: 3977521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.